Wellington Management Group
PDLI

Wellington Management Group’s PDL BioPharma, Inc. PDLI Stock Holding History

Wellington Management Group’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-212,287
Closed -$558K – 2324
2018
Q3 		$558K Sell
212,287
-1,290,198
-86% -$3.17M ﹤0.01% 2011
2018
Q2 		$3.52M Sell
1,502,485
-668
-0% -$1.86K ﹤0.01% 1591
2018
Q1 		$4.42M Buy
1,503,153
+44,020
+3% +$120K ﹤0.01% 1523
2017
Q4 		$4M Hold
1,459,133
– – ﹤0.01% 1542
2017
Q3 		$4.95M Sell
1,459,133
-76,704
-5% -$213K ﹤0.01% 1479
2017
Q2 		$3.79M Sell
1,535,837
-49,707
-3% -$114K ﹤0.01% 1511
2017
Q1 		$3.6M Sell
1,585,544
-5,706
-0.4% -$12.6K ﹤0.01% 1560
2016
Q4 		$3.37M Buy
1,591,250
+257,804
+19% +$719K ﹤0.01% 1541
2016
Q3 		$4.47M Buy
1,333,446
+942
+0.1% +$2.99K ﹤0.01% 1423
2016
Q2 		$4.18M Hold
1,332,504
– – ﹤0.01% 1406
2016
Q1 		$4.44M Hold
1,332,504
– – ﹤0.01% 1393
2015
Q4 		$4.72M Buy
1,332,504
+472,707
+55% +$1.98M ﹤0.01% 1376
2015
Q3 		$4.33M Buy
859,797
+74,488
+9% +$427K ﹤0.01% 1397
2015
Q2 		$5.05M Buy
785,309
+100,842
+15% +$675K ﹤0.01% 1405
2015
Q1 		$4.82M Buy
684,467
+168,512
+33% +$1.22M ﹤0.01% 1466
2014
Q4 		$3.98M Buy
515,955
+12,221
+2% +$96.7K ﹤0.01% 1510
2014
Q3 		$3.76M Buy
503,734
+195,534
+63% +$1.82M ﹤0.01% 1517
2014
Q2 		$2.98M Sell
308,200
-413,235
-57% -$3.68M ﹤0.01% 1589
2014
Q1 		$6M Buy
721,435
+36,300
+5% +$311K ﹤0.01% 1398
2013
Q4 		$5.78M Buy
685,135
+89,700
+15% +$756K ﹤0.01% 1416
2013
Q3 		$4.75M Buy
595,435
+37,300
+7% +$300K ﹤0.01% 1454
2013
Q2 		$4.31M Buy
+558,135
New +$4.35M ﹤0.01% 1462

Other funds holding PDLI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Wellington Management Group's PDLI Position: Q4 2018 in Review

Wellington Management Group sold out of PDL BioPharma, Inc. (PDLI) in Q4 2018, closing a stake of 212,287 shares — an estimated $558K sold.

Wellington Management Group first reported a position in PDLI in Q2 2013 and held it in 22 quarters. The position peaked at $6M in Q1 2014. 154 funds tracked by Wall St. Rank hold PDLI as of Q4 2018.

  • Wellington Management Group reported no remaining PDL BioPharma, Inc. position as of Q4 2018 after selling out during the quarter.
  • Wellington Management Group sold 212,287 PDL BioPharma, Inc. shares in Q4 2018, an estimated $558K.
  • Wellington Management Group first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 22 quarters.
  • Wellington Management Group's PDL BioPharma, Inc. position peaked at $6M in Q1 2014.
  • 154 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2018.

Based on Wellington Management Group's 13F filing for Q4 2018, filed 14 Feb 2019.